Cooley Wins Eight LBG Life Sciences EMEA Awards
London – 4 June 2026 – Cooley and its life sciences practice won eight awards, including Licensing & Collaboration Firm of the Year for the second consecutive year, and Venture Capital Firm of the Year at the Legal Benchmarking Group (LBG) Life Sciences EMEA (Europe, the Middle East and Africa) Awards.
Partner Frances Stocks Allen received Licensing & Collaboration Lawyer of the Year, and associate Alexandra Paterson was recognised as M&A Rising Star.
Additionally, the firm earned four Impact Deal awards based on representations of:
- EsoBiotech on its $1 billion acquisition by AstraZeneca
- BioNTech on its multibillion-dollar co-commercialisation collaboration agreement with Bristol Myers Squibb
- Hengrui Pharma on its exclusive licensing agreement with GSK, valued up to $12.5 billion, to develop up to 12 medicines
- Araris Biotech on its $1.14 billion acquisition by Japan-based Taiho Pharmaceutical
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.
Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.
Related Contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.